_ap_ufes{"success":true,"siteUrl":"www.investmentyogi.com/w","urls":{"Home":"http://www.investmentyogi.com","Category":"http://www.investmentyogi.com/category/alternative-investment/","Archive":"http://www.investmentyogi.com/2015/02/","Post":"http://www.investmentyogi.com/salient-aspects-of-union-budget-2015/","Page":"http://www.investmentyogi.com/nri/","Nav_menu_item":"http://www.investmentyogi.com/trending/","Wpcf7_contact_form":"http://www.investmentyogi.com/?post_type=wpcf7_contact_form&p=5591","Flare":"http://www.investmentyogi.com/flare/email/"}}_ap_ufee

Yogi Zone

Useful articles for your finance management by our team of experts

Dr. Reddys Laboratories Stock Review – Nifty 50

0 Flares 0 Flares ×

Stock NameDr. Reddys Lab

Listed Exchange: NSE, BSE

NSE Code- DRREDDY

P/E or Price to Equity Ratio: 28.72

EPS or Earnings per Share: 91.89

P/B or Price to book value ratio: 5.77

Market Capitalization: Rs. 44,897 crore

Current Price on NSE – 2645.45

52 Week Low – 1720.40

52 Week High – 2665.50

Our Review of Dr. Reddy’s Stock

Dr. Reddy’s lab belongs to the pharmaceutical sector. If you had invested in the stock in 2004, you would have invested at a level of 677, which implies a profit of almost 300%.

Franklin India, HDFC and Birla Sunlife together hold more than 19 lakh shares of Dr. Reddys lab. It has given great returns for its loyal investors. The stock looks very attractive for the long term given its current price, dividend history and strong financials.

 

0 Flares Facebook 0 Google+ 0 Twitter 0 Email -- 0 Flares ×